PGMA meets RP-born CEO of giant Zuellig pharmaceutical company
ZURICH, Switzerland (22 January) -- President Gloria Macapagal-Arroyo will meet with Philippine-born Zuellig Pharmaceuticals chairman and CEO Stephen Zuellig on Wednesday, her first working day here.
The meeting between the President and the executive of the giant pharmaceutical firm is set for Wednesday morning, local time, (5:30 p.m. in Manila) at the Savoy Hotel.
Dr. Zuellig, who was born in the Philippines, has steered the pharmaceutical company to its present status as the largest distributor of medicines in Southeast Asia, Australia, New Zealand, South Korea, Taiwan and China.
Founded in the Philippines in 1901 by his father, Dr. Fredrick Edward Zuellig, a migrant from Switzerland, the pharmaceutical company is a truly global Filipino company with a turnover of some $5 billion annually.
As part of its corporate social responsibility, the pharmaceutical company has distinguished itself as a leading example of government-private sector partnership.
In January 2007, Zuellig forged an agreement with the Philippine International Trading Corporation (PITC) on the manufacture of some 24 generic drugs under the government's half-priced medicines for the poor program.
Dr. Zuellig's pro-bono assistance was also instrumental in the unfreezing in 2004 of the Marcos funds in Switzerland.
He has been serving as Monaco's honorary consul to the Philippines for the last 40 years.
For his contributions to the country and the Filipino people, the President awarded Dr. Zuellig with the Order of Lakandula (Grand Cross) with the Rank of Bayani in Malacanang in May 2007. (OPS) [top]